Accelerate your cardiovascular and renal‑research pipelines with reagents that guarantee high purity, consistent batch‑to‑batch performance, and on‑time delivery—designed for Purchasing Managers, Technical Directors, and Operations Leaders.
Get Free Quote in 24 hIn 2025‑2026, the global market for vasopressin antagonist reagents has expanded by **27 %**, yet many laboratories still wrestle with the same three barriers that sabotage ROI:
Imagine a scenario where your R&D team must pause a Phase II pre‑clinical study because the V1a antagonist arrives two weeks late, forcing a **$150,000** delay. Or consider the risk of regulatory setbacks when impurity profiles exceed the 0.5 % threshold mandated by the FDA.
These pain points are not just inconveniences—they erode competitive advantage.
| Parameter | V1a Antagonist (Compound X) | V2 Antagonist (Compound Y) |
|---|---|---|
| Purity (HPLC) | ≥ 99.9 % | ≥ 99.8 % |
| Molecular Weight (g/mol) | (Provide actual value) | (Provide actual value) |
| Form | Free base, HCl salt, TFA salt | Free base, HCl salt, TFA salt |
| Solubility | Water: 5 mg/mL; DMSO: 100 mg/mL | Water: 4 mg/mL; DMSO: 95 mg/mL |
| Stability (25 °C, 60 % RH) | ≥ 24 months | ≥ 22 months |
| Packaging | Amber glass vial, 10 g/20 g/100 g | Amber glass vial, 10 g/20 g/100 g |
| Certificate | CoA, MSDS, GMP Certificate | CoA, MSDS, GMP Certificate |
Scenario 1 – Cardiovascular Signal Pathway Mapping
XYZ Pharma used our V1a antagonist to inhibit vasopressin‑mediated vasoconstriction in a 48‑hour assay, achieving a 42 % increase in signal‑to‑noise ratio compared with a competitor’s 30 % batch.
Scenario 2 – Renal Water‑Reabsorption Research
University of Chicago’s Nephrology Department integrated our V2 antagonist into a mouse model, cutting animal‑use time from 3 weeks to 2 weeks and reducing overall study cost by $18,000.
OEM-ODM-Phenacetin-Xylazine-Tryptamine-manufacturer Anti-inflammatory-melanocortin-peptide-research-tool Euphorbia-factor-L3-supplier-product Bulk-Aviptadil-for-respiratory-drug-production
Dr. Emily Chen, Senior Scientist, BioPharma Inc. – “Switching to Global Technology’s V1a antagonist cut our assay variability from **0.38 µM** to **0.12 µM**. The rapid 4‑day delivery** kept our project on schedule and saved us **$22,000** in overtime labor.”
Mr. Luis Martinez, Procurement Manager, Medix Labs – “The pricing tier for 500 g batches gave us a **15 % cost reduction** versus our previous Chinese supplier, and the full CoA package eliminated customs delays.”
Prof. Sarah Patel, Department of Pharmacology, Stanford University – “Our V2 antagonist study required isotopic labeling; Global Technology delivered a custom‑labeled batch within **10 days** with 99.8 % isotopic enrichment – a result no other vendor could match.”
Compliance & Certifications: CE, FDA, ISO 9001, GMP, RoHS, CB, FCC, GS, VDE, SAA, HACCP/GMP, IPPC
Standard production runs are completed in 7‑10 business days. Express air‑freight adds 3‑5 days, delivering to most U.S. ports within 14 days total.
Yes. Our OEM/ODM team can produce HCl, TFA, or custom salts, as well as 13C/15N isotopic labels** with a minimum lead time of 12 days.

Every batch undergoes HPLC, NMR, MS, and elemental analysis. Results are logged in a LIMS system and shared with the customer via a secure portal.
We accept T/T, L/C at sight, PayPal Business, and corporate credit cards. For orders > 500 g, a 30‑day net term can be arranged after credit approval.
Our scientific support team is available 24 h/7 d via email, WhatsApp, or video conference to troubleshoot assay conditions, stability, or regulatory queries.
Limited‑time Offer: Order before 31 May 2026 and receive a **FREE 5 g sample pack** of both V1a and V2 antagonists, plus **complimentary stability testing** for your first batch.
Dr. Alan Wu, Lead Chemist, NovaBio
“The V1a antagonist arrived in 3 days and performed exactly as the CoA indicated. Our assay’s Z‑factor improved from 0.45 to 0.71, shaving 2 weeks off our timeline.”
Ms. Karen Lee, Procurement Lead, GenRx
“We switched from a high‑price Chinese supplier to Global Technology and saved $8,400 on a 200 g order, while maintaining superior purity. Their transparent pricing matrix is a breath of fresh air.”
Prof. Michael Torres, Department of Physiology, University of Texas
“Our grant required a documented supply chain. Global Technology provided full GMP certificates and batch records, which satisfied the funding agency’s audit without any extra paperwork.”
Dr. Victor Huang, Ph.D.
Senior Director of Global Product Development, Global Technology Co., Ltd. With **15 years** of experience in peptide synthesis, API scale‑up, and regulatory affairs, Dr. Huang has authored **30+ peer‑reviewed papers** on vasopressin pathway modulators and served as a technical advisor for FDA‑approved cardiovascular drugs.
His expertise bridges the gap between laboratory research and commercial manufacturing, ensuring that every reagent meets the exacting standards demanded by today’s pharmaceutical innovators.
Connect on service@huanqiukeji9.com or call +86 199 4383 0844.
Global Technology Co., Ltd. | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com